Herbal targeting of mitochondrial dynamic proteins in low-density lipoprotein driven atherosclerosis in vitro - Report - MDSpire

Targeting Mitochondrial Dynamics with Herbal Extracts in Atherosclerosis Induced by Low-Density Lipoprotein: An In Vitro Study

  • By

  • Zhanna Dzampaeva

  • Rodion Saveljev

  • July 21, 2026

Share

Targeting Mitochondrial Dynamics with Herbal Extracts in Atherosclerosis

Overview

This study investigates the effects of herbal extracts on mitochondrial dynamics in endothelial cells exposed to oxidized LDL.

Background

Mitochondrial dysfunction is a significant factor in the early stages of atherosclerosis, contributing to endothelial injury and cardiovascular diseases. This study explores the potential of herbal extracts to modulate mitochondrial dynamics and improve endothelial cell function.

Data Highlights

ExtractEffect on Mitochondrial DynamicsGene Expression Changes
Rosmarinus officinalisPreserved ΔψmIncreased FUNDC1, OPTN
Cynara cardunculusEnhanced mitophagyUpregulated PINK1, PARKIN
Myrtus communisPreserved mitochondrial architectureIncreased FUNDC1, OPTN

Key Findings

  • All extracts preserved mitochondrial membrane potential in healthy HUVECs.
  • In the ox-LDL model, extracts downregulated pro-fission genes (DRP1, FIS1, MFF).
  • Extracts restored expression of fusion proteins (MFN2, OPA1).
  • Cynara cardunculus significantly upregulated mitophagy-related genes (PINK1, PARKIN).
  • Rosmarinus officinalis and Myrtus communis increased receptor-mediated clearance pathways (FUNDC1, OPTN).
  • All extracts enhanced antioxidant enzyme expression (CAT) and suppressed pro-inflammatory MAPK8 (JNK).

Clinical Implications

The findings suggest that herbal extracts may serve as adjunctive therapies to support endothelial health and mitigate atherosclerosis progression. Further research is needed to explore the clinical applicability of these extracts in cardiovascular disease prevention.

Conclusion

Herbal extracts demonstrate potential in protecting endothelial cells from oxidized LDL-induced damage by modulating mitochondrial dynamics.

Related Resources & Content

  1. Basic Research in Cardiology, 2020 -- Macrophage Proliferation Inhibition is Key to Plaque Regression Following Cholesterol Reduction
  2. Frontiers in Cardiovascular Medicine, 2026 -- Therapeutic Targeting of Mitochondrial Dysfunction in Heart Failure: A Systematic Review & Meta-Analysis of Clinical Outcomes
  3. Basic Research in Cardiology, 2013 -- Loss of Sirt3 Does Not Influence Atherosclerosis Progression but Promotes Weight Gain and Disrupts Rapid Metabolic Adaptation in LDL Receptor Knockout Mice: Consequences for Cardiovascular Risk Factor Development
  4. ACC/AHA Issue Updated Guideline for Managing Lipids, Cholesterol - American College of Cardiology, 2026
  5. Basic Research in Cardiology — NLRP3 Facilitates Macrophage Proliferation Induced by Lipids in Established Atherosclerotic Conditions
  6. ACC/AHA Issue Updated Guideline for Managing Lipids, Cholesterol - American College of Cardiology
  7. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke | New England Journal of Medicine
  8. Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association - Professional Heart Daily | American Heart Association

Original Source(s)

Related Content